Provided by Tiger Trade Technology Pte. Ltd.

HENLIUS

64.800
+0.1000.15%
Volume:558.92K
Turnover:35.48M
Market Cap:35.22B
PE:38.91
High:64.900
Open:64.900
Low:62.050
Close:64.700
52wk High:92.000
52wk Low:15.200
Shares:543.49M
HK Float Shares:163.43M
Volume Ratio:0.90
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.665
ROE:27.54%
ROA:4.97%
PB:9.37
PE(LYR):38.91
PS:5.51

Loading ...

Wall Street Hedge Fund Point72 Increases Stake in HENLIUS (02696) with HK$20.37 Million Investment

Stock News
·
Sep 04

Hong Kong Stocks Movement | HENLIUS (02696) Surges Nearly 6% in Afternoon Trading Following FDA Approval of BILDYOS and BILPREVDA in the US

Stock News
·
Sep 03

Organon, Henlius Says US FDA Approves Denosumab Biosimilars

MT Newswires Live
·
Sep 02

BRIEF-HKEX Announces Disciplinary Action Against Shanghai Henlius Biotech

Reuters
·
Sep 02

Organon & Co. Secures FDA Approval for BILDYOS and BILPREVDA, Expanding Access to Critical Bone Care Treatments in the U.S

Reuters
·
Sep 02

Shanghai Henlius Biotech Inc. Censured by Hong Kong Stock Exchange; Former Director Criticized and Directed to Undergo Training

Reuters
·
Sep 02

HKEX - Criticises Former Executive Director and Chief Executive Officer

THOMSON REUTERS
·
Sep 02

HKEX - Shanghai Henlius Biotech and Former CEO Did Not Contest Respective Breaches, Agreed to Accept Sanctions

THOMSON REUTERS
·
Sep 02

Hong Kong Stock Market Preview | Stablecoin Ordinance Receives 77 Application Intentions in First Month, HKEX (00388) Optimizes Margin Collateral Arrangements

Stock News
·
Sep 02

HENLIUS (02696): FDA Approves HLX14 (Denosumab, US Brand Names: BILDYOS® and BILPREVDA®) for Eight Indications Including Osteoporosis Treatment in Specific Patient Populations

Stock News
·
Sep 01

Shanghai Henlius Biotech Inc. Receives FDA Approval for Two Products, BILDYOS® and BILPREVDA®, for Eight Indications Including Osteoporosis

Reuters
·
Sep 01

Shanghai Henlius Biotech Inc - U.S. FDA Approves Hlx14 Products for Eight Indications

THOMSON REUTERS
·
Sep 01

HENLIUS (02696) Proposes to Grant a Total of 67,500 Share Options and 8.75 Restricted Share Units

Stock News
·
Aug 29

HENLIUS (02696): Wenjie Zhang Reappointed as Chairman of Fourth Board of Directors

Stock News
·
Aug 29

Shanghai Henlius Biotech Inc. Conducted Extraordinary General Meeting

Reuters
·
Aug 29

Hong Kong Stocks Movement | HENLIUS (02696) Surges Over 8% Intraday as HLX43 Completes First US Patient Dosing, Three Core Products to Be Featured at WCLC

Stock News
·
Aug 29

Press Release: Henlius Keeps Steady Growth in H1 2025: Overseas Product Profits Soar 200%+, Innovation Fuels Global Reach

Dow Jones
·
Aug 25

Shanghai Henlius Biotech's Profit Jumps in H1

MT Newswires Live
·
Aug 25

HENLIUS (02696) Reports Interim Results with Shareholders' Profit of RMB 390 Million, Up 0.99% YoY, Overseas Product Profits Surge Over 200% YoY

Stock News
·
Aug 25

BRIEF-Shanghai Henlius Biotech Logs H1 Net Income RMB 390.1 Mln

Reuters
·
Aug 25